End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 16.2M | Sales 2023 | 16M | Capitalization | 5.47M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | 3M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K | Net cash position 2023 | 875K | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CannaVEST Corp
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 14-06-15 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 18-12-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 14-06-15 |
Jamie Corroon
BRD | Director/Board Member | 54 | 22-07-20 |
William McCorkle
BRD | Director/Board Member | 56 | 22-10-20 |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |